Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.028 AUD | +3.70% | -3.45% | -20.00% |
02:38am | Chimeric Therapeutics Appoints COO; Shares Rise 4% | MT |
May. 01 | Chimeric Therapeutics' CEO/Managing Director Steps Down; Shares Plunge 20% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 14.94M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Treats First Patient in Phase 1B Leukemia Trial